Description
Vesilute Peptide Description
Vesilute peptide is a research-grade Khavinson bioregulator composed of the dipeptide L-Glutamic Acid (Glu) and L-Aspartic Acid (Asp). It is intended for laboratory and scientific research investigating the cellular biology of the urinary system and prostate.
Preclinical research has explored Vesilute’s potential interactions with cellular regulatory pathways involved in bladder tissue, prostate function, smooth muscle activity, and microcirculation. It has also been studied in experimental models related to urinary tract physiology, including chronic cystitis, benign prostatic hyperplasia (BPH), and prostatitis.
Manufactured to high research-grade standards, Vesilute provides investigators with a reliable peptide for studying urinary tract cellular mechanisms, tissue homeostasis, and peptide-mediated biological regulation. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
Vesilute Peptide Benefits
- Investigated for its potential to support bladder cellular function.
- Studied for its role in prostate tissue biology and cellular regulation.
- May help researchers better understand urinary tract physiology.
- Explored for its potential immunomodulatory and anti-inflammatory mechanisms in urinary tissues.
- Investigated for supporting healthy cellular communication within the urinary system.
- Studied for its potential influence on smooth muscle function in the bladder and prostate.
- May contribute to research on microcirculation and blood flow regulation in urinary tissues.
- Explored for its effects on cellular proliferation and tissue regeneration.
- Investigated for its role in gene expression and peptide-mediated cellular regulation.
- Studied in experimental models of chronic cystitis and bladder inflammation.
- Explored in research related to benign prostatic hyperplasia (BPH) and prostate enlargement.
- Investigated for its potential involvement in prostatitis research models.
- May support laboratory studies examining prostate gland function and reproductive biology.
- Studied for its potential influence on sperm quality and male fertility mechanisms.
- Investigated for its role in maintaining tissue homeostasis within the urinary tract.
- May support research into age-related changes affecting bladder and prostate tissues.
- Explored for its effects on biochemical pathways involved in urinary system health.
- Investigated as part of peptide bioregulator research focused on cellular maintenance and tissue integrity.
The Vesilute Peptide Specifications
| Property | Value |
|---|---|
| Peptide Sequence | H-Glu-Asp-OH |
| Molecular Formula | C₉H₁₄N₂O₇ |
| Molecular Weight | 262.20 g/mol |
| CAS Number | 3918-84-1 |
| PubChem CID | 99716 |
Vesilute Peptide Dosage Table
| Product | Dosage | Administration | Timing |
| Vesilute | 10-20mg | Subcutaneous Injection | Morning |
